Lovelace Biomedical Research Institute
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2019 | 18,927,855 | 20,698,355 | −1,770,500 | 16.0 | 28% |
| 2020 | 76,388,415 | 74,188,991 | 2,199,424 | 17.9 | 28% |
| 2021 | 89,255,628 | 80,362,730 | 8,892,898 | 19.3 | 27% |
| 2022 | 71,507,956 | 66,188,457 | 5,319,499 | 21.9 | 27% |
| 2023 | 112,131,523 | 94,680,185 | 17,451,338 | 26.3 | 23% |
In its most recent public year (2023), this organization brought in $17,451,338 more than it spent. Its reserves stood at about 26.3 months of spending, up from 16 in 2019. Staff pay was 23% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works